Objective: This study evaluates the use of a preoperative single oral dose of dexamethasone for the prevention and control of postendodontic pain.
Study Design: Forty-seven patients were randomly assigned to 2 groups: placebo and dexamethasone (4 mg). The medications were administered 1 hour before the start of endodontic treatment. Postoperative pain was assessed after 4, 12, 24, and 48 hours.
Results: Dexamethasone resulted in a statistically significant reduction in postendodontic pain at 4 and 12 hours (P < .05). However, no statistical difference (P > .05) was observed at 24 and 48 hours (Mann-Whitney test). The placebo group exhibited higher rescue medication intake (P < .05; Student t test). No side effects were reported for any of the medications used.
Conclusion: Preoperative single oral dose of dexamethasone substantially reduced postendodontic pain. Further studies are needed to evaluate the applicability of these findings to other clinical conditions and drug regimens.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tripleo.2009.05.014 | DOI Listing |
J Endod
January 2025
Department of Endodontics, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229. Electronic address:
Introduction: Persistent post-endodontic pain following endodontic therapy is a rare but substantial clinical challenge. Mechanisms that mediate peripheral neuropathy and/or central sensitization likely play a pivotal role in its development and chronification. The objective of this case series is to describe a management plan for persistent post-endodontic pain and provide prescription guidelines using a standardized "Gabapentin Pyramid Protocol" for clinical practice.
View Article and Find Full Text PDFJ Conserv Dent Endod
November 2024
Department of Conservative Dentistry and Endodontics, YMT Dental College and Hospital, Mumbai, Maharashtra, India.
Context: Postoperative pain occurs in 25%-60% of patients following endodontic treatment. It can significantly impact a patient's quality of life and requires timely management or, preferably, prevention.
Aims: The present systematic review was conducted aiming to analyze randomized controlled trials that compared postoperative pain in patients whose canals were shaped by XPS versus other endodontic file systems.
J Endod
December 2024
Department of Endodontics, Nihon University School of Dentistry, Tokyo, Japan; Division of Advanced Dental Treatment, Dental Research Center, Nihon University School of Dentistry, Tokyo, Japan.
Introduction: We have recently reported the clinical efficacy of mirogabalin for occlusal pain due to post-traumatic trigeminal neuropathic pain (PTTN-occlusal pain) after endodontic treatment according to the International Classification of Orofacial Pain criteria. This study aimed to determine the mirogabalin administration period and timing of dose reduction and suspension for treating this condition based on managing a certain number of cases.
Methods: Patients diagnosed with PTTN-occlusal pain after or during endodontic treatment were included in the study.
J Dent (Shiraz)
December 2024
Dep. of Endodontics, School of Dentistry, Bushehr University of Medical Sciences, Bushehr, Iran.
Statement Of The Problem: Considering side effects of non-steroidal anti-inflammatory drugs (NSAIDs), herbal medicine including might help reduce the pain.
Purpose: The present study aimed to compare the effects of premedication with essential oil of and ibuprofen on post-endodontic pain.
Materials And Method: The present randomized clinical trial study was conducted on 60 patients with symptomatic irreversible pulpitis of mandibular first or second molars.
J Conserv Dent Endod
September 2024
Department of Conservative Dentistry and Endodontics, Sri Ramachandra Dental College and Hospital, Sri Ramachandra Institute of Higher Education and Research (SRIHER - DU), Chennai, Tamil Nadu, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!